Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 82804-161

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 82804-161). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82804-161-90 (Atorvastatin20mg90count)

Label for Atorvastatin Calcium 20 mg film-coated tablets, containing 90 tablets per package. Manufactured by Annora Pharma Pvt. Ltd., India, and packaged by Proficient Rx LP, Thousand Oaks, CA. The tablets are described as white to off-white, oval, biconvex, debossed with '20' and 'A 54'. Storage instructions and batch details are included.*

FDA Label Image

Atorvastatinfigure2. (Atorvastatinfigure2)

A cumulative incidence line graph comparing Atorvastatin and placebo over a time span of 3.5 years. The x-axis represents years, and the y-axis represents cumulative incidence percentage. Two lines show lower incidence for Atorvastatin relative to placebo, with statistical significance noted.*

FDA Label Image

Atorvastatinfigure3. (Atorvastatinfigure3)

A line graph comparing cumulative hazard percentages over time between placebo and atorvastatin groups. The x-axis represents time to first primary endpoint through four years of follow-up, and the y-axis shows cumulative hazard percentage. The atorvastatin group shows a lower cumulative hazard than the placebo group, with a hazard ratio (HR) of 0.63 and p-value of 0.001 indicated on the graph.*

FDA Label Image

Atorvastatinfigure4. (Atorvastatinfigure4)

A line chart depicting the time to first major cardiovascular endpoint in years for two dosages of atorvastatin calcium tablets, 10 mg and 80 mg. The y-axis shows the subject experiencing event percentage, indicating lower event rates over time with the 80 mg dose compared to 10 mg.*

FDA Label Image

Atorvastatinfigure9 (Atorvastatinfigure9)

FDA Label Image

Atorvastatinfigure1. (Image 01)

Chemical structure of Atorvastatin Calcium, showing the molecular arrangement including phenyl groups, hydroxyl groups, and calcium ion complexation with water molecules, corresponding to the active ingredient in Atorvastatin Calcium tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.